Watch ADGM. Know when insiders buy.
One email the day a filing lands. Free.
ADGM
Adagio Medical Holdings, Inc.
0.56
+0.02 +4.25%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $12.5MP/E —DIV YIELD —FCF YIELD -132.28%REV TTM $0NET INCOME −$27.1MNET DEBT $17.1M52W 0.38 – 2.36SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | — | — | −$4.9M | −$6.7M | — | -0.30 | −$5.3M | $6K | −$5.3M | Aug 11 |
| Q1 2026 · Mar 31 | $0 | — | — | −$5.2M | −$7M | — | -0.31 | −$4.1M | $2K | −$4.1M | May 12 |
| Q4 2025 · Dec 31derived | $0 | — | — | −$4M | −$3.3M | — | -0.09 | −$4.1M | −$491K | −$3.6M | Mar 27 |
| Q3 2025 · Sep 30 | $0 | −100.0% | — | −$5.7M | −$10.1M | — | -0.66 | −$3M | $520K | −$3.5M | Nov 12 |
| Q2 2025 · Jun 30 | $0 | −100.0% | — | −$4.7M | −$3.9M | — | -0.35 | −$4.7M | $10K | −$4.7M | Aug 11 |
| Q1 2025 · Mar 31 | $0 | −100.0% | — | −$7.4M | −$7.7M | — | -0.51 | −$7.2M | $335K | −$7.5M | May 12 |
| Q3 2024 · Sep 30 | — | — | — | — | −$8.2M | — | -8.34 | — | — | — | Nov 12 |
| Q2 2024 · Jun 30 | $254K | — | -168.5% | −$6.7M | −$5.7M | — | -7.35 | −$6.9M | $175K | −$7.1M | Aug 14 |
| Q1 2024 · Mar 31 | $26K | — | -1984.6% | −$8.8M | −$8M | — | -10.28 | −$6.7M | $162K | −$6.9M | May 15 |
| Q4 2023 · Dec 31derived | $78K | — | -328.2% | −$5.3M | −$8.6M | — | -11.33 | −$7.1M | $20K | −$7.1M | Mar 27 |
| Q3 2023 · Sep 30 | $41K | — | -517.1% | −$9.1M | −$10.8M | — | -14.15 | — | — | — | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$21.9M | −$25.1M | — | -1.51 | −$19M | $374K | −$19.4M | — | — |
| FY2024 · to Dec 31 | — | — | — | — | — | — | — | — | — | — | — |
| FY2023 · to Dec 31 | $300K | -335.3% | −$27.9M | −$36.6M | -12196.7% | -48.16 | −$25.7M | $333K | −$26M | — | — |
Every number comes from Adagio Medical Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.